vs
Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $57.3M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 7.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 4.7%).
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
HSTM vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.7M | $57.3M |
| Net Profit | — | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 3.0% | -82.2% |
| Net Margin | — | -83.0% |
| Revenue YoY | 7.4% | 36.9% |
| Net Profit YoY | — | -9.6% |
| EPS (diluted) | $0.09 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.7M | $57.3M | ||
| Q3 25 | $76.5M | $51.3M | ||
| Q2 25 | $74.4M | $48.5M | ||
| Q1 25 | $73.5M | $32.7M | ||
| Q4 24 | $74.2M | $41.8M | ||
| Q3 24 | $73.1M | $33.3M | ||
| Q2 24 | $71.6M | $29.1M | ||
| Q1 24 | $72.8M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $6.1M | $-52.9M | ||
| Q2 25 | $5.4M | $-46.6M | ||
| Q1 25 | $4.3M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $5.7M | $-43.6M | ||
| Q2 24 | $4.2M | $-32.3M | ||
| Q1 24 | $5.2M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 3.0% | -82.2% | ||
| Q3 25 | 9.9% | -102.6% | ||
| Q2 25 | 7.9% | -93.4% | ||
| Q1 25 | 6.0% | -143.7% | ||
| Q4 24 | 6.3% | -98.6% | ||
| Q3 24 | 8.9% | -132.0% | ||
| Q2 24 | 6.2% | -139.2% | ||
| Q1 24 | 7.8% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | 8.0% | -103.1% | ||
| Q2 25 | 7.2% | -96.1% | ||
| Q1 25 | 5.9% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 7.8% | -131.2% | ||
| Q2 24 | 5.8% | -110.9% | ||
| Q1 24 | 7.2% | -544.4% |
| Q4 25 | $0.09 | $-0.73 | ||
| Q3 25 | $0.20 | $-0.82 | ||
| Q2 25 | $0.18 | $-0.75 | ||
| Q1 25 | $0.14 | $-0.81 | ||
| Q4 24 | $0.16 | $-0.71 | ||
| Q3 24 | $0.19 | $-0.73 | ||
| Q2 24 | $0.14 | $-0.55 | ||
| Q1 24 | $0.17 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.2M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $354.0M | $139.1M |
| Total Assets | $520.4M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.2M | $388.9M | ||
| Q3 25 | $53.5M | $416.1M | ||
| Q2 25 | $52.1M | $291.0M | ||
| Q1 25 | $77.3M | $314.5M | ||
| Q4 24 | $59.5M | $320.6M | ||
| Q3 24 | $57.5M | $298.4M | ||
| Q2 24 | $46.1M | $319.1M | ||
| Q1 24 | $52.4M | $201.2M |
| Q4 25 | $354.0M | $139.1M | ||
| Q3 25 | $349.2M | $148.8M | ||
| Q2 25 | $350.6M | $-11.9M | ||
| Q1 25 | $362.8M | $18.9M | ||
| Q4 24 | $359.4M | $21.7M | ||
| Q3 24 | $355.5M | $11.2M | ||
| Q2 24 | $349.2M | $39.3M | ||
| Q1 24 | $344.9M | $61.6M |
| Q4 25 | $520.4M | $480.2M | ||
| Q3 25 | $499.9M | $506.9M | ||
| Q2 25 | $500.1M | $372.7M | ||
| Q1 25 | $524.0M | $386.7M | ||
| Q4 24 | $510.8M | $392.3M | ||
| Q3 24 | $502.8M | $363.6M | ||
| Q2 24 | $499.6M | $381.8M | ||
| Q1 24 | $511.6M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.2M | $-25.4M |
| Free Cash FlowOCF − Capex | $13.0M | — |
| FCF MarginFCF / Revenue | 16.3% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | $-25.4M | ||
| Q3 25 | $18.0M | $-26.6M | ||
| Q2 25 | $5.0M | $-23.3M | ||
| Q1 25 | $27.1M | $-40.4M | ||
| Q4 24 | $11.2M | $-18.8M | ||
| Q3 24 | $19.1M | $-25.2M | ||
| Q2 24 | $6.5M | $-29.1M | ||
| Q1 24 | $20.9M | $-40.7M |
| Q4 25 | $13.0M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $26.0M | — | ||
| Q4 24 | $11.0M | — | ||
| Q3 24 | $18.8M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $20.2M | — |
| Q4 25 | 16.3% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 35.4% | — | ||
| Q4 24 | 14.8% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 27.8% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.96× | — | ||
| Q2 25 | 0.93× | — | ||
| Q1 25 | 6.25× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.34× | — | ||
| Q2 24 | 1.55× | — | ||
| Q1 24 | 4.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
RYTM
Segment breakdown not available.
